|1.||Jin, Jong-Shiaw: 9 articles (03/2013 - 09/2007)|
|2.||Weed, Scott A: 8 articles (05/2013 - 08/2003)|
|3.||Yu, Cheng-Ping: 6 articles (06/2011 - 01/2009)|
|4.||Schuuring, Ed: 6 articles (03/2008 - 11/2003)|
|5.||Garcia, Joe G N: 5 articles (11/2015 - 08/2007)|
|6.||Lin, Chih-Kung: 5 articles (03/2013 - 01/2009)|
|7.||Tsai, Wen-Chiuan: 5 articles (03/2013 - 09/2007)|
|8.||Nieh, Shin: 5 articles (03/2013 - 01/2009)|
|9.||Koleske, Anthony J: 5 articles (04/2012 - 03/2007)|
|10.||van Rossum, Agnes G S H: 5 articles (05/2006 - 11/2003)|
|1.||Renal Cell Carcinoma (Grawitz Tumor)
08/01/2011 - "The immunoreactive score of p421 cortactin, but not that of cortactin and pY466 cortactin, was significantly greater in SRCC than in conventional renal cell carcinoma (P < .001). "
08/01/2011 - "To clarify the clinical and prognostic significance of cortactin and phosphorylated cortactin in patients with sarcomatoid renal cell carcinoma (SRCC). "
08/01/2011 - "Pathologic significance and prognostic value of phosphorylated cortactin expression in patients with sarcomatoid renal cell carcinoma."
08/01/2009 - "Our findings support the potential targeting of survivin and cortactin for the development of novel therapeutic strategies for renal cell carcinoma."
08/01/2009 - "Immunohistochemical analysis of cortactin and survivin expression (scored on a scale of 0-400) was performed in 124 renal cell carcinomas including clear cell renal cell carcinoma (CRCC), papillary RCC (PRCC), CRCC with sarcomatoid differentiation (SRCC), chromophobe RCC (ChRCC), and CRCC with granular cell differentiation (GRCC). "
|2.||Clear Cell Adenocarcinoma
03/28/2014 - "To study the effects of cortactin on the tumor biology of SGC-7901 cells and identify the mechanism involved in the process. "
03/01/2011 - "Due to its frequent overexpression in advanced, invasive cancers and its general role in regulating branched actin assembly at multiple cellular locations, cortactin has been the subject of intense study. "
02/01/2010 - "We sought to study the role of cortactin in melanocytic tumor progression using immunohistochemistry on human tissues. "
12/01/2009 - "The present study aimed to further clarify the significance of the interaction between cortactin and ZO-1 in cancer progression. "
07/08/2008 - "Recently, many studies have documented a role for cortactin in promoting cell motility and invasion, including a critical role in invadopodia, actin rich-subcellular protrusions associated with degradation of the extracellular matrix by cancer cells. "
|4.||Breast Neoplasms (Breast Cancer)
01/01/2011 - "This study was designed to analyze the cortactin status in breast cancer using TMA and to investigate the relationship of cortactin status to breast cancer biology. "
12/01/2010 - "Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study."
01/01/2015 - "Fe65 Suppresses Breast Cancer Cell Migration and Invasion through Tip60 Mediated Cortactin Acetylation."
01/01/2014 - "In breast cancer, the cortactin is over expressed leading to increased cellular motility and invasiveness. "
03/01/2011 - "Our findings suggest a novel mechanism by which an EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. "
10/26/2000 - "In this study we report on the detection of the autologous antibody response to putative oncogene, human cortactin using serological analysis of breast carcinoma expression library. "
08/01/2015 - "However, the significance of cortactin and HDAC6 remains unclear in uncommon histologic variant human prostatic foamy gland carcinoma (PfCa). "
08/01/2015 - "Expression and significance of cortactin and HDAC6 in human prostatic foamy gland carcinoma."
05/01/2015 - "Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinoma."
01/01/2013 - "Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma."
|1.||Small Interfering RNA (siRNA)
|3.||Proteins (Proteins, Gene)
|5.||Actin-Related Protein 2-3 Complex (Arp2 3 Complex)
|6.||Epidermal Growth Factor Receptor (EGF Receptor)
|7.||Matrix Metalloproteinase 14 (MT1-MMP)
|9.||Epidermal Growth Factor (EGF)
|10.||Protein-Tyrosine Kinases (Tyrosine Kinase)
|3.||Drug Therapy (Chemotherapy)